• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性肺损伤和急性呼吸窘迫综合征的替代和自然疗法。

Alternative and Natural Therapies for Acute Lung Injury and Acute Respiratory Distress Syndrome.

机构信息

Division of Pulmonology, Norton Thoracic Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA.

Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Florida, Gainesville, FL, USA.

出版信息

Biomed Res Int. 2018 May 16;2018:2476824. doi: 10.1155/2018/2476824. eCollection 2018.

DOI:10.1155/2018/2476824
PMID:29862257
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5976962/
Abstract

INTRODUCTION

Acute respiratory distress syndrome (ARDS) is a complex clinical syndrome characterized by acute inflammation, microvascular damage, and increased pulmonary vascular and epithelial permeability, frequently resulting in acute respiratory failure and death. Current best practice for ARDS involves "lung-protective ventilation," which entails low tidal volumes and limiting the plateau pressures in mechanically ventilated patients. Although considerable progress has been made in understanding the pathogenesis of ARDS, little progress has been made in the development of specific therapies to combat injury and inflammation.

AREAS COVERED

In recent years, several natural products have been studied in experimental models and have been shown to inhibit multiple inflammatory pathways associated with acute lung injury and ARDS at a molecular level. Because of the pleiotropic effects of these agents, many of them also activate antioxidant pathways through nuclear factor erythroid-related factor 2, thereby targeting multiple pathways. Several of these agents are prescribed for treatment of inflammatory conditions in the Asian subcontinent and have shown to be relatively safe.

EXPERT COMMENTARY

Here we review natural remedies shown to attenuate lung injury and inflammation in experimental models. Translational human studies in patients with ARDS may facilitate treatment of this devastating disease.

摘要

简介

急性呼吸窘迫综合征(ARDS)是一种复杂的临床综合征,其特征为急性炎症、微血管损伤以及肺血管和上皮通透性增加,常导致急性呼吸衰竭和死亡。目前 ARDS 的最佳治疗方法是“肺保护性通气”,即对机械通气患者采用小潮气量和限制平台压。尽管人们在理解 ARDS 的发病机制方面取得了相当大的进展,但在开发针对损伤和炎症的特定治疗方法方面却鲜有进展。

涵盖领域

近年来,已有多种天然产物在实验模型中进行了研究,并已证明其可在分子水平上抑制与急性肺损伤和 ARDS 相关的多种炎症途径。由于这些药物的多效性,其中许多药物还通过核因子红细胞相关因子 2 激活抗氧化途径,从而针对多种途径。这些药物中有几种被用于治疗亚洲次大陆的炎症性疾病,并且已被证明相对安全。

专家评论

本文综述了在实验模型中已被证明可减轻肺损伤和炎症的天然疗法。对 ARDS 患者进行转化性人体研究可能有助于治疗这种毁灭性疾病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ca5/5976962/818410439e7c/BMRI2018-2476824.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ca5/5976962/766e5ea533d5/BMRI2018-2476824.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ca5/5976962/818410439e7c/BMRI2018-2476824.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ca5/5976962/766e5ea533d5/BMRI2018-2476824.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ca5/5976962/818410439e7c/BMRI2018-2476824.002.jpg

相似文献

1
Alternative and Natural Therapies for Acute Lung Injury and Acute Respiratory Distress Syndrome.急性肺损伤和急性呼吸窘迫综合征的替代和自然疗法。
Biomed Res Int. 2018 May 16;2018:2476824. doi: 10.1155/2018/2476824. eCollection 2018.
2
The efficacy of mesenchymal stromal cell-derived therapies for acute respiratory distress syndrome-a meta-analysis of preclinical trials.间充质基质细胞衍生疗法治疗急性呼吸窘迫综合征的疗效:临床前试验的荟萃分析。
Respir Res. 2020 Nov 20;21(1):307. doi: 10.1186/s12931-020-01574-y.
3
Adenosine at the Interphase of Hypoxia and Inflammation in Lung Injury.腺苷在肺损伤的缺氧和炎症交界区。
Front Immunol. 2021 Jan 14;11:604944. doi: 10.3389/fimmu.2020.604944. eCollection 2020.
4
Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device.通过重症监护病房类型设备在猪急性呼吸窘迫综合征模型中进行卤化剂输送
J Vis Exp. 2020 Sep 24(163). doi: 10.3791/61644.
5
Natural product derived phytochemicals in managing acute lung injury by multiple mechanisms.天然产物衍生的植物化学物质通过多种机制管理急性肺损伤。
Pharmacol Res. 2021 Jan;163:105224. doi: 10.1016/j.phrs.2020.105224. Epub 2020 Sep 29.
6
Therapeutic implications of mesenchymal stem cells in acute lung injury/acute respiratory distress syndrome.间充质干细胞在急性肺损伤/急性呼吸窘迫综合征中的治疗意义
Stem Cell Res Ther. 2013 May 2;4(3):45. doi: 10.1186/scrt193.
7
Targeting MALAT1 and miRNA-181a-5p for the intervention of acute lung injury/acute respiratory distress syndrome.针对 MALAT1 和 miRNA-181a-5p 干预急性肺损伤/急性呼吸窘迫综合征。
Respir Med. 2020 Dec;175:106210. doi: 10.1016/j.rmed.2020.106210. Epub 2020 Nov 4.
8
Paracrine factors from mesenchymal stem cells: a proposed therapeutic tool for acute lung injury and acute respiratory distress syndrome.间充质干细胞的旁分泌因子:一种用于急性肺损伤和急性呼吸窘迫综合征的潜在治疗工具。
Int Wound J. 2014 Apr;11(2):114-21. doi: 10.1111/iwj.12202. Epub 2013 Dec 26.
9
The HDL from septic-ARDS patients with composition changes exacerbates pulmonary endothelial dysfunction and acute lung injury induced by cecal ligation and puncture (CLP) in mice.脓毒症相关性急性呼吸窘迫综合征患者的载脂蛋白 A-I 降低的高密度脂蛋白加剧盲肠结扎穿孔术诱导的小鼠肺血管内皮功能障碍和急性肺损伤。
Respir Res. 2020 Nov 4;21(1):293. doi: 10.1186/s12931-020-01553-3.
10
Dexamethasone fails to improve bleomycin-induced acute lung injury in mice.地塞米松未能改善博来霉素诱导的小鼠急性肺损伤。
Physiol Rep. 2019 Nov;7(21):e14253. doi: 10.14814/phy2.14253.

引用本文的文献

1
Luteolin: exploring its therapeutic potential and molecular mechanisms in pulmonary diseases.木犀草素:探索其在肺部疾病中的治疗潜力和分子机制
Front Pharmacol. 2025 Feb 12;16:1535555. doi: 10.3389/fphar.2025.1535555. eCollection 2025.
2
Qingfei Huoxue Decoction and Its Active Component Narirutin Alleviate LPS-Induced Acute Lung Injury by Regulating TLR4/NF-κB Pathway Mediated Inflammation.清肺活血汤及其活性成分橙皮苷通过调节TLR4/NF-κB通路介导的炎症减轻脂多糖诱导的急性肺损伤。
J Inflamm Res. 2024 Oct 21;17:7503-7520. doi: 10.2147/JIR.S480101. eCollection 2024.
3
Multipotent mesenchymal stromal/stem cell-based therapies for acute respiratory distress syndrome: current progress, challenges, and future frontiers.

本文引用的文献

1
Acute respiratory distress syndrome.急性呼吸窘迫综合征
Eur Respir Rev. 2017 Apr 26;26(144). doi: 10.1183/16000617.0116-2016. Print 2017 Jun 30.
2
Fifty Years of Research in ARDS. Respiratory Mechanics in Acute Respiratory Distress Syndrome.急性呼吸窘迫综合征的呼吸力学:50 年的研究进展。
Am J Respir Crit Care Med. 2017 Oct 1;196(7):822-833. doi: 10.1164/rccm.201612-2495CI.
3
Optimal Strategies for Severe Acute Respiratory Distress Syndrome.重症急性呼吸窘迫综合征的优化策略
基于多能间充质基质/干细胞的急性呼吸窘迫综合征治疗:当前进展、挑战和未来前沿。
Braz J Med Biol Res. 2024 Oct 14;57:e13219. doi: 10.1590/1414-431X2024e13219. eCollection 2024.
4
Identification and Analysis of PANoptosis-Related Genes in Sepsis-Induced Lung Injury by Bioinformatics and Experimental Verification.通过生物信息学和实验验证鉴定及分析脓毒症诱导的肺损伤中与PAN细胞焦亡相关的基因
J Inflamm Res. 2024 Mar 28;17:1941-1956. doi: 10.2147/JIR.S452608. eCollection 2024.
5
Recent progress in mesenchymal stem cell-based therapy for acute lung injury.间充质干细胞治疗急性肺损伤的研究进展。
Cell Tissue Bank. 2024 Jun;25(2):677-684. doi: 10.1007/s10561-024-10129-0. Epub 2024 Mar 11.
6
Role of ATF3 triggering M2 macrophage polarization to protect against the inflammatory injury of sepsis through ILF3/NEAT1 axis.ATF3 通过 ILF3/NEAT1 轴触发 M2 巨噬细胞极化以防止脓毒症的炎症损伤。
Mol Med. 2024 Feb 23;30(1):30. doi: 10.1186/s10020-023-00711-9.
7
LC-QToF chemical profiling of Euphorbia grantii Oliv. and its potential to inhibit LPS-induced lung inflammation in rats via the NF-κB, CY450P2E1, and P38 MAPK14 pathways.LC-QToF 化学分析大狼毒及其通过 NF-κB、CY450P2E1 和 P38 MAPK14 通路抑制 LPS 诱导的大鼠肺炎症的潜力。
Inflammopharmacology. 2024 Feb;32(1):461-494. doi: 10.1007/s10787-023-01298-7. Epub 2023 Aug 12.
8
Uridine Alleviates Sepsis-Induced Acute Lung Injury by Inhibiting Ferroptosis of Macrophage.尿苷通过抑制巨噬细胞铁死亡缓解脓毒症诱导的急性肺损伤。
Int J Mol Sci. 2023 Mar 7;24(6):5093. doi: 10.3390/ijms24065093.
9
Cryptotanshinone attenuates LPS-induced acute lung injury by regulating metabolic reprogramming of macrophage.隐丹参酮通过调节巨噬细胞的代谢重编程减轻脂多糖诱导的急性肺损伤。
Front Med (Lausanne). 2023 Jan 13;9:1075465. doi: 10.3389/fmed.2022.1075465. eCollection 2022.
10
Alarmins and MicroRNAs, a New Axis in the Genesis of Respiratory Diseases: Possible Therapeutic Implications.警报素和 microRNAs,呼吸系统疾病发病机制中的新轴心:可能的治疗意义。
Int J Mol Sci. 2023 Jan 16;24(2):1783. doi: 10.3390/ijms24021783.
Crit Care Clin. 2017 Apr;33(2):259-275. doi: 10.1016/j.ccc.2016.12.010.
4
Fifty Years of Research in ARDS. The Epidemiology of Acute Respiratory Distress Syndrome. A 50th Birthday Review.ARDS 研究五十年。急性呼吸窘迫综合征的流行病学。五十岁生日回顾。
Am J Respir Crit Care Med. 2017 Apr 1;195(7):860-870. doi: 10.1164/rccm.201609-1773CP.
5
Fifty Years of Research in ARDS. Insight into Acute Respiratory Distress Syndrome. From Models to Patients.ARDS 研究五十年。急性呼吸窘迫综合征的洞察。从模型到患者。
Am J Respir Crit Care Med. 2017 Jul 1;196(1):18-28. doi: 10.1164/rccm.201612-2415CI.
6
Acute respiratory distress syndrome.急性呼吸窘迫综合征
Clin Med (Lond). 2016 Dec;16(Suppl 6):s66-s70. doi: 10.7861/clinmedicine.16-6-s66.
7
GOLDEN anniversary of the acute respiratory distress syndrome: still much work to do!急性呼吸窘迫综合征 50 周年:仍有许多工作要做!
Curr Opin Crit Care. 2017 Feb;23(1):4-9. doi: 10.1097/MCC.0000000000000378.
8
Acute Lung Injury: A Clinical and Molecular Review.急性肺损伤:临床与分子综述
Arch Pathol Lab Med. 2016 Apr;140(4):345-50. doi: 10.5858/arpa.2015-0519-RA.
9
Callicarpa japonica Thunb. reduces inflammatory responses: a mouse model of lipopolysaccharide-induced acute lung injury.紫珠减轻炎症反应:脂多糖诱导的急性肺损伤小鼠模型
Int Immunopharmacol. 2015 May;26(1):174-80. doi: 10.1016/j.intimp.2015.01.025. Epub 2015 Feb 4.
10
The acute respiratory distress syndrome: from mechanism to translation.急性呼吸窘迫综合征:从机制到转化
J Immunol. 2015 Feb 1;194(3):855-60. doi: 10.4049/jimmunol.1402513.